BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-12@pharmaconomics
DTSTAMP:20260707T003557Z
DTSTART;VALUE=DATE:20260822
DTEND;VALUE=DATE:20260823
SUMMARY:CAPR PDUFA — Deramiocel
DESCRIPTION:The FDA's approval decision on Deramiocel for Duchenne muscular dystrophy is due Aug 22\, 2026. A green light opens the market\; a complete response letter (CRL) usually sinks the stock.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1133869/000110465926057221/capr-20260507xex99d1.htm\n\nTrack it: https://pharmaconomics.com/e/12
URL:https://pharmaconomics.com/e/12
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:CAPR catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR